Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines.
Proc Natl Acad Sci U S A
; 120(33): e2303567120, 2023 08 15.
Article
in En
| MEDLINE
| ID: mdl-37556502
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Nanoparticles
/
COVID-19
Type of study:
Guideline
Limits:
Humans
Language:
En
Journal:
Proc Natl Acad Sci U S A
Year:
2023
Type:
Article